Opeña, Liezlann A.

HRN: 28-67-97  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2026
AMPICILLIN 1GM (VIAL)
03/18/2026
03/19/2026
IV
2gms
Q6hrs
PROM
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: